Regeneron Pharmaceuticals Market Cap

Regeneron Pharmaceuticals has a market cap or net worth of €64.03 billion as of February 2, 2026. Its market cap has decreased by -12.95% in one year.

Market Cap

64.03B

Enterprise Value

50.43B

Revenue

12.22B

Ranking

n/a

PE Ratio

16.69

Stock Price

€634.00

Market Cap Chart

Since July 20, 1992, Regeneron Pharmaceuticals's market cap has increased from 131.41M to 64.03B, an increase of 48,625.16%. That is a compound annual growth rate of 20.26%.

Market Cap History

Date	Market Cap	% Change
Jan 30, 2026	64.03B	-5.07%
Dec 31, 2025	67.45B	-8.88%
Dec 31, 2024	74.03B	-12.40%
Dec 29, 2023	84.50B	17.20%
Dec 30, 2022	72.10B	24.19%
Dec 31, 2021	58.06B	39.28%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Rheinmetall AG	81.74B
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München	65.38B
Deutsche Bank Aktiengesellschaft	63.36B
Mercedes-Benz Group AG	55.14B
Merck KGaA	54.59B
Infineon Technologies AG	54.16B
Bayerische Motoren Werke Aktiengesellschaft	53.83B
Volkswagen AG	51.53B

Market Cap Rankings